Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

HER2/neu peptide fragment provokes immune response against tumor cells

Oct. 18, 1996

Japanese researchers report new antitumor antibiotics

Oct. 18, 1996

Kyowa Hakko reports antiestrogenic agents

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Lyme disease vaccine claimed by University of Minnesota

Oct. 18, 1996

Magainin discloses LAP for microbial infections

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...